A lawyer said he had used the cartoon image of a dragon in a business suit as a logo for his firm, Dragon Lawyers, to symbolize “aggressive representation.” By Michael Levenson A purple dragon ...

Against the backdrop of World Immunization Week, Dr Reddy’s Laboratories Ltd and Sanofi Healthcare India have expanded their partnership to bring in Beyfortus – a novel drug to prevent ...

Several social media users are sharing a Tesla logo ‘upside down’ meme claiming that the stylized ‘T’ when upturned looks like a Ku Klux Klan (KKK) hood. A TikTok user, @ ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden child could be emerging in the form of Beyfortus. During its first ...

The price you pay for Beyfortus may depend on factors such as your child’s dosage and whether you have health insurance. Financial assistance may be available to help you with the cost of Beyfortus.

Logos for household brands become so ingrained in our brains that it’s hard to believe any detail about them can go unnoticed. And yet there are dozens of secret messages in company logos, and ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

Our Vaccines business grew 26%. This increase benefited from an element of phasing in the flu and Beyfortus sales. However, the global rollout of Beyfortus provided a strong contribution as well.

Wall Street promptly began trying to weigh the compound’s marketplace odds after Merck & Co. Inc. detailed positive data from the phase IIb/III trial known as MK-1654-004 with clesrovimab, an ...

In the RSV market for infants, AstraZeneca and Sanofi’s Beyfortus leads the way. It achieved sales of 547 million euros ($592 million) in 2023. While cross-trial comparisons carry inherent ...

Paris, October 9, 2024. Sanofi advances its ambition to protect all infants from respiratory syncytial virus (RSV) disease with new Beyfortus (nirsevimab) data to be presented at the Infectious ...

"We're proud to offer BEYFORTUS doses to help protect every eligible baby in the US this RSV season. This accomplishment aimed at equitable access was made possible through close partnership with ...